RGLBX
Price
$25.97
Change
+$0.07 (+0.27%)
Updated
Jul 2 closing price
Net Assets
17.27B
RWICX
Price
$70.53
Change
+$0.25 (+0.36%)
Updated
Jul 2 closing price
Net Assets
134.69B
Interact to see
Advertisement

RGLBX vs RWICX

Header iconRGLBX vs RWICX Comparison
Open Charts RGLBX vs RWICXBanner chart's image
American Funds Global Insight R-2
Price$25.97
Change+$0.07 (+0.27%)
VolumeN/A
Net Assets17.27B
American Funds Capital World Gr&Inc R3
Price$70.53
Change+$0.25 (+0.36%)
VolumeN/A
Net Assets134.69B
RGLBX vs RWICX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 135B vs. RGLBX (17.3B). RWICX pays higher dividends than RGLBX: RWICX (1.21) vs RGLBX (0.21). RGLBX was incepted earlier than RWICX: RGLBX (6 years) vs RWICX (23 years). RGLBX (1.52) is less costly to investors than RWICX (1.06). RWICX is a more actively managed with annual turnover of: 27.00 vs. RGLBX (21.00). RGLBX (250) and RWICX (250) have matching initial minimum investment requirements. RGLBX annual gain was more profitable for investors over the last year : 14.52 vs. RWICX (9.25). RGLBX return over 5 years is better than : 60.96 vs. RWICX (50.29).
RGLBXRWICXRGLBX / RWICX
Total Expense Ratio1.521.06143%
Annual Report Gross Expense Ratio1.521.06143%
Fund Existence6 years23 years-
Gain YTD12.57012.68199%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets17.3B135B13%
Annual Yield % from dividends0.211.2118%
Returns for 1 year14.529.25157%
Returns for 3 years50.0348.08104%
Returns for 5 years60.9650.29121%
Returns for 10 yearsN/A58.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSBR7.780.41
+5.56%
Champions Oncology
OI15.570.44
+2.91%
O-I Glass
AMLX6.570.16
+2.57%
Amylyx Pharmaceuticals
APLM6.560.16
+2.50%
Apollomics Inc
SWK71.561.15
+1.63%
Stanley Black & Decker